世界の軽度から中等度のアトピー性皮膚炎の治療市場：市場規模・現状・予測

• 英文タイトル：Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N7574
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当資料は、軽度から中等度のアトピー性皮膚炎の治療のグローバル市場について調査・分析したレポートで、種類別（放射線治療、薬物治療）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・軽度から中等度のアトピー性皮膚炎の治療の世界市場規模
・主要企業別市場シェア
・軽度から中等度のアトピー性皮膚炎の治療の世界市場規模：種類別（放射線治療、薬物治療）
・軽度から中等度のアトピー性皮膚炎の治療の世界市場規模：用途別（病院薬局、小売薬局、オンライン薬局）
・軽度から中等度のアトピー性皮膚炎の治療のアメリカ市場規模（種類別、用途別）
・軽度から中等度のアトピー性皮膚炎の治療のヨーロッパ市場規模（種類別、用途別）
・軽度から中等度のアトピー性皮膚炎の治療の中国市場規模（種類別、用途別）
・軽度から中等度のアトピー性皮膚炎の治療の日本市場規模（種類別、用途別）
・軽度から中等度のアトピー性皮膚炎の治療の東南アジア市場規模（種類別、用途別）
・軽度から中等度のアトピー性皮膚炎の治療のインド市場規模（種類別、用途別）
・軽度から中等度のアトピー性皮膚炎の治療の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・軽度から中等度のアトピー性皮膚炎の治療の世界市場予測（2019年-2025年）
・軽度から中等度のアトピー性皮膚炎の治療の地域別市場予測（2019年-2025年）
...

Mild-to-moderate atopic dermatitis is a chronic inflammatory skin disease often confined to the flexural surfaces of the body and usually begins in childhood.Drug treatment can further be segmented into antihistamines, antibiotics, emollients, corticosteroids, and calcineurin inhibitors.
North America leads the market for mid-to-moderate atopic dermatitis reasons being lifestyle changes, new product innovations, and early treatment adoption.
In 2018, the global Mild-to-Moderate Atopic Dermatitis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Mild-to-Moderate Atopic Dermatitis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Mild-to-Moderate Atopic Dermatitis Treatment development in United States, Europe and China.

The key players covered in this study
Novartis
Pfizer
Sanofi
Anacor Pharmaceuticals
Astellas Pharma
Meda Pharmaceuticals
Regeneron Pharmaceuticals
Valeant Pharmaceuticals

Market segment by Type, the product can be split into
Radiation Treatment
Drug Treatment

Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Mild-to-Moderate Atopic Dermatitis Treatment status, future forecast, growth opportunity, key market and key players.
To present the Mild-to-Moderate Atopic Dermatitis Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Mild-to-Moderate Atopic Dermatitis Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Radiation Treatment
1.4.3 Drug Treatment
1.5 Market by Application
1.5.1 Global Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Mild-to-Moderate Atopic Dermatitis Treatment Market Size
2.2 Mild-to-Moderate Atopic Dermatitis Treatment Growth Trends by Regions
2.2.1 Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Regions (2014-2025)
2.2.2 Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Manufacturers
3.1.1 Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Mild-to-Moderate Atopic Dermatitis Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Mild-to-Moderate Atopic Dermatitis Treatment Key Players Head office and Area Served
3.3 Key Players Mild-to-Moderate Atopic Dermatitis Treatment Product/Solution/Service
3.4 Date of Enter into Mild-to-Moderate Atopic Dermatitis Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2014-2019)
4.2 Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Mild-to-Moderate Atopic Dermatitis Treatment Market Size (2014-2019)
5.2 Mild-to-Moderate Atopic Dermatitis Treatment Key Players in United States
5.3 United States Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type
5.4 United States Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application

6 Europe
6.1 Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size (2014-2019)
6.2 Mild-to-Moderate Atopic Dermatitis Treatment Key Players in Europe
6.3 Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type
6.4 Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application

7 China
7.1 China Mild-to-Moderate Atopic Dermatitis Treatment Market Size (2014-2019)
7.2 Mild-to-Moderate Atopic Dermatitis Treatment Key Players in China
7.3 China Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type
7.4 China Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application

8 Japan
8.1 Japan Mild-to-Moderate Atopic Dermatitis Treatment Market Size (2014-2019)
8.2 Mild-to-Moderate Atopic Dermatitis Treatment Key Players in Japan
8.3 Japan Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type
8.4 Japan Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Mild-to-Moderate Atopic Dermatitis Treatment Market Size (2014-2019)
9.2 Mild-to-Moderate Atopic Dermatitis Treatment Key Players in Southeast Asia
9.3 Southeast Asia Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type
9.4 Southeast Asia Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application

10 India
10.1 India Mild-to-Moderate Atopic Dermatitis Treatment Market Size (2014-2019)
10.2 Mild-to-Moderate Atopic Dermatitis Treatment Key Players in India
10.3 India Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type
10.4 India Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Mild-to-Moderate Atopic Dermatitis Treatment Market Size (2014-2019)
11.2 Mild-to-Moderate Atopic Dermatitis Treatment Key Players in Central & South America
11.3 Central & South America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type
11.4 Central & South America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application

12 International Players Profiles
12.1 Novartis
12.1.1 Novartis Company Details
12.1.2 Company Description and Business Overview
12.1.3 Mild-to-Moderate Atopic Dermatitis Treatment Introduction
12.1.4 Novartis Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2014-2019)
12.1.5 Novartis Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Mild-to-Moderate Atopic Dermatitis Treatment Introduction
12.2.4 Pfizer Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 Sanofi
12.3.1 Sanofi Company Details
12.3.2 Company Description and Business Overview
12.3.3 Mild-to-Moderate Atopic Dermatitis Treatment Introduction
12.3.4 Sanofi Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2014-2019)
12.3.5 Sanofi Recent Development
12.4 Anacor Pharmaceuticals
12.4.1 Anacor Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Mild-to-Moderate Atopic Dermatitis Treatment Introduction
12.4.4 Anacor Pharmaceuticals Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2014-2019)
12.4.5 Anacor Pharmaceuticals Recent Development
12.5 Astellas Pharma
12.5.1 Astellas Pharma Company Details
12.5.2 Company Description and Business Overview
12.5.3 Mild-to-Moderate Atopic Dermatitis Treatment Introduction
12.5.4 Astellas Pharma Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2014-2019)
12.5.5 Astellas Pharma Recent Development
12.6 Meda Pharmaceuticals
12.6.1 Meda Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Mild-to-Moderate Atopic Dermatitis Treatment Introduction
12.6.4 Meda Pharmaceuticals Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2014-2019)
12.6.5 Meda Pharmaceuticals Recent Development
12.7 Regeneron Pharmaceuticals
12.7.1 Regeneron Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Mild-to-Moderate Atopic Dermatitis Treatment Introduction
12.7.4 Regeneron Pharmaceuticals Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2014-2019)
12.7.5 Regeneron Pharmaceuticals Recent Development
12.8 Valeant Pharmaceuticals
12.8.1 Valeant Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Mild-to-Moderate Atopic Dermatitis Treatment Introduction
12.8.4 Valeant Pharmaceuticals Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2014-2019)
12.8.5 Valeant Pharmaceuticals Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Mild-to-Moderate Atopic Dermatitis Treatment Key Market Segments
Table Key Players Mild-to-Moderate Atopic Dermatitis Treatment Covered
Table Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size Market Share by Type 2014-2025
Figure Radiation Treatment Figures
Table Key Players of Radiation Treatment
Figure Drug Treatment Figures
Table Key Players of Drug Treatment
Table Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Mild-to-Moderate Atopic Dermatitis Treatment Report Years Considered
Table Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size 2014-2025 (Million US$)
Figure Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Regions 2014-2019
Figure Global Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Regions 2014-2019
Figure Global Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Manufacturers (2014-2019)
Figure Global Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Manufacturers in 2018
Table Global Mild-to-Moderate Atopic Dermatitis Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Mild-to-Moderate Atopic Dermatitis Treatment Product/Solution/Service
Table Date of Enter into Mild-to-Moderate Atopic Dermatitis Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size Share by Type (2014-2019)
Figure Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size Market Share by Type (2014-2019)
Table Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size Share by Application (2014-2019)
Figure Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size Market Share by Application (2014-2019)
Figure Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue Market Share by Application in 2018
Figure United States Mild-to-Moderate Atopic Dermatitis Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Mild-to-Moderate Atopic Dermatitis Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Mild-to-Moderate Atopic Dermatitis Treatment Market Share (2018-2019)
Table United States Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Type (2014-2019)
Table United States Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Application (2014-2019)
Figure Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Mild-to-Moderate Atopic Dermatitis Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Mild-to-Moderate Atopic Dermatitis Treatment Market Share (2018-2019)
Table Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Type (2014-2019)
Table Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Application (2014-2019)
Figure China Mild-to-Moderate Atopic Dermatitis Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Mild-to-Moderate Atopic Dermatitis Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Mild-to-Moderate Atopic Dermatitis Treatment Market Share (2018-2019)
Table China Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2014-20189) (Million US$)
Table China Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Type (2014-2019)
Table China Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2014-2019) (Million US$)
Table China Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Application (2014-2019)
Figure Japan Mild-to-Moderate Atopic Dermatitis Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Mild-to-Moderate Atopic Dermatitis Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Mild-to-Moderate Atopic Dermatitis Treatment Market Share (2018-2019)
Table Japan Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Type (2014-2019)
Table Japan Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Mild-to-Moderate Atopic Dermatitis Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Mild-to-Moderate Atopic Dermatitis Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Mild-to-Moderate Atopic Dermatitis Treatment Market Share (2018-2019)
Table Southeast Asia Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Type (2014-2019)
Table Southeast Asia Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Application (2014-2019)
Figure India Mild-to-Moderate Atopic Dermatitis Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Mild-to-Moderate Atopic Dermatitis Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Mild-to-Moderate Atopic Dermatitis Treatment Market Share (2018-2019)
Table India Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2014-2019) (Million US$)
Table India Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Type (2014-2019)
Table India Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2014-2019) (Million US$)
Table India Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Application (2014-2019)
Figure Central & South America Mild-to-Moderate Atopic Dermatitis Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Mild-to-Moderate Atopic Dermatitis Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Mild-to-Moderate Atopic Dermatitis Treatment Market Share (2018-2019)
Table Central & South America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Type (2014-2019)
Table Central & South America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Application (2014-2019)
Table Novartis Company Details
Table Novartis Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2014-2019) (Million US$)
Figure Novartis Revenue Growth Rate in Mild-to-Moderate Atopic Dermatitis Treatment Business (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Mild-to-Moderate Atopic Dermatitis Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Mild-to-Moderate Atopic Dermatitis Treatment Business (2014-2019)
Table Sanofi Recent Development
Table Anacor Pharmaceuticals Company Details
Table Anacor Pharmaceuticals Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2014-2019)(Million US$)
Figure Anacor Pharmaceuticals Revenue Growth Rate in Mild-to-Moderate Atopic Dermatitis Treatment Business (2014-2019)
Table Anacor Pharmaceuticals Recent Development
Table Astellas Pharma Company Details
Table Astellas Pharma Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2014-2019)(Million US$)
Figure Astellas Pharma Revenue Growth Rate in Mild-to-Moderate Atopic Dermatitis Treatment Business (2014-2019)
Table Astellas Pharma Recent Development
Table Meda Pharmaceuticals Company Details
Table Meda Pharmaceuticals Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2014-2019)(Million US$)
Figure Meda Pharmaceuticals Revenue Growth Rate in Mild-to-Moderate Atopic Dermatitis Treatment Business (2014-2019)
Table Meda Pharmaceuticals Recent Development
Table Regeneron Pharmaceuticals Company Details
Table Regeneron Pharmaceuticals Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2014-2019)(Million US$)
Figure Regeneron Pharmaceuticals Revenue Growth Rate in Mild-to-Moderate Atopic Dermatitis Treatment Business (2014-2019)
Table Regeneron Pharmaceuticals Recent Development
Table Valeant Pharmaceuticals Company Details
Table Valeant Pharmaceuticals Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2014-2019)(Million US$)
Figure Valeant Pharmaceuticals Revenue Growth Rate in Mild-to-Moderate Atopic Dermatitis Treatment Business (2014-2019)
Table Valeant Pharmaceuticals Recent Development
Table Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size Share by Regions (2019-2025)
Figure Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size Share by Regions in 2025
Figure United States Mild-to-Moderate Atopic Dermatitis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Mild-to-Moderate Atopic Dermatitis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Mild-to-Moderate Atopic Dermatitis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Mild-to-Moderate Atopic Dermatitis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Mild-to-Moderate Atopic Dermatitis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Mild-to-Moderate Atopic Dermatitis Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Product (2019-2025)
Figure Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Product in 2025
Table Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2019-2025)
Figure Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界の放射線皮膚炎の治療市場：市場規模・現状・予測

Global Radiation Dermatitis Treatment Market Size, Status and Forecast 2019-2025
QYR9N7919 2019年6月14日 95Pages
当資料は、放射線皮膚炎の治療のグローバル市場について調査・分析したレポートで、種類別（経口薬、局所、包帯）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
<...

世界の放射線皮膚炎治療市場：市場規模・現状・予測

Global Radiation Dermatitis Therapies Market Size, Status and Forecast 2019-2025
QYR9N7918 2019年6月14日 92Pages
当資料は、放射線皮膚炎治療のグローバル市場について調査・分析したレポートで、種類別（経口薬、局所、包帯）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界のナルコレプシー治療市場：市場規模・現状・予測

Global Narcolepsy Treatment Market Size, Status and Forecast 2019-2025
QYR9N7625 2019年6月14日 96Pages
当資料は、ナルコレプシー治療のグローバル市場について調査・分析したレポートで、種類別（オキシベイトナトリウム、抗うつ薬、中枢神経系興奮剤、その他）、用途別（カタプレキシーを伴う原発性ナルコレプシー、片麻痺のない原発性ナルコレプシー、疾患によるナルコレプシー、不特定ナルコレプシー）、主要地域別（アメリ...

世界のハンチントン病の治療市場：市場規模・現状・予測

Global Huntington’s Disease Treatment Market Size, Status and Forecast 2019-2025
QYR9N7325 2019年6月14日 97Pages
当資料は、ハンチントン病の治療のグローバル市場について調査・分析したレポートで、種類別（対症療法、疾患修飾療法）、用途別（病院、外来手術センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界の消化不良の治療市場：市場規模・現状・予測

Global Digestive Distress Treatment Market Size, Status and Forecast 2019-2025
QYR9N7099 2019年6月14日 94Pages
当資料は、消化不良の治療のグローバル市場について調査・分析したレポートで、種類別（上部消化管、下部消化管）、用途別（病院薬局、オンライン薬局、ドラッグストア、専門クリニック）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれてい...

世界のハンセン病治療市場：市場規模・現状・予測

Global Leprosy Treatment Market Size, Status and Forecast 2019-2025
QYR9N7442 2019年6月14日 95Pages
当資料は、ハンセン病治療のグローバル市場について調査・分析したレポートで、種類別（スルホン、フェナジン誘導体、抗結核薬、その他）、用途別（病院、診療所、薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界の末梢神経障害の治療市場：市場規模・現状・予測

Global Peripheral Neuropathy Treatment Market Size, Status and Forecast 2019-2025
QYR9N7794 2019年6月14日 92Pages
当資料は、末梢神経障害の治療のグローバル市場について調査・分析したレポートで、種類別（カルシウムチャンネルα2 - デルタ配位子、抗うつ薬、オピオイド、その他）、用途別（プラチナエージェント、タキサン、ビンカアルカロイド、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、...

世界のQT延長症候群の治療市場：市場規模・現状・予測

Global Long QT Syndrome Treatment Market Size, Status and Forecast 2019-2025
QYR9N7468 2019年6月14日 90Pages
当資料は、QT延長症候群の治療のグローバル市場について調査・分析したレポートで、種類別（薬、手術療法）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・QT...

世界の多形性膠芽腫（GBM）市場：市場規模・現状・予測

Global Glioblastoma Multiforme Treatment (GBM) Market Size, Status and Forecast 2019-2025
QYR9N7247 2019年6月14日 92Pages
当資料は、多形性膠芽腫（GBM）のグローバル市場について調査・分析したレポートで、種類別（化学療法、放射線療法、遺伝子治療、分子バイオテクノロジー）、用途別（ベバコズマブ、カルムスティン、テモゾロマイド）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測...

世界の黄斑変性症の治療市場：市場規模・現状・予測

Global Macular Degeneration Treatment Market Size, Status and Forecast 2019-2025
QYR9N7494 2019年6月14日 99Pages
当資料は、黄斑変性症の治療のグローバル市場について調査・分析したレポートで、種類別（ルセンティス、アイリーア、アバスチン、その他）、用途別（病院、アイクリニック、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています...

世界の放射線皮膚炎の治療市場：市場規模・現状・予測 The pathophysiology of a radiation skin reaction is a combination of radiation injury and the subsequent inflammatory response and can occur at both the entrance and exit site of the irradiation.The major factor driving the radiation dermatitis treatment market is the increasing prevalence of cancer…
世界の放射線皮膚炎治療市場：市場規模・現状・予測 Radiation dermatitis is a common side effect of radiotherapy, which is one of the most frequently used treatments for cancer.In 2018, the global Radiation Dermatitis Therapies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019…
世界のクッシング病治療市場：市場規模・現状・予測 Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…
世界の結節性痒疹の治療市場：市場規模・現状・予測 Prurigo nodularis (PN), also known as nodular prurigo, is a skin disease characterised by pruritic (itchy) nodules which usually appear on the arms or legs.Among products, antihistamines are foreseen to exhibit a higher CAGR in the global prurigo nodularis treatment market. In 2018, the global Pruri…
世界の副甲状腺機能低下症の治療市場：市場規模・現状・予測 In 2018, the global Hypoparathyroidism Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Hypoparathyroidism Treatment status, future forecast, growth opportunity, key market a…